Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer

In recent years, significant advances have been made in the management of metastatic colorectal cancer. Traditionally, an improvement in overall survival has been considered the “gold standard”—the most convincing measure of efficacy. However, overall survival requires larger patient numbers and lon...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Gill, S., Berry, S., Biagi, J., Butts, C., Buyse, M., Chen, E., Jonker, D., Mărginean, C., Samson, B., Stewart, J., Thirlwell, M., Wong, R., Maroun, J.A.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Multimed Inc. 2011
Θέματα:
Medical Oncology
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3176908/
https://ncbi.nlm.nih.gov/pubmed/21969810
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια